I. Moroo

发表

Insulin receptor mRNA in the substantia nigra in Parkinson's disease

Hiroshi Kimura, Tatsuo Yamada, Takayuki Yamamoto, 1996, Neuroscience Letters.

Geranylgeranyl-Pyrophosphate, an Isoprenoid of Mevalonate Cascade, Is a Critical Compound for Rat Primary Cultured Cortical Neurons to Protect the Cell Death Induced by 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibition

M. Kitagawa, I. Tatsuno, Yasushi Saito, 2000, The Journal of Neuroscience.

Delayed onset postural tremor caused by parietal lesion

K. Hirayama, I. Moroo, M. Nakajima, 1997, Movement disorders : official journal of the Movement Disorder Society.

Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates mitogen-activated protein kinase (MAPK) in cultured rat astrocytes

Tomoaki Tanaka, I. Tatsuno, I. Moroo, 1998, Brain Research.

Immunohistochemistry using antibodies to α-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues

I. Moroo, T. Yamada, T. Toyoda, 1994, Neuroscience Letters.

Increased concentration of C4d complement protein in the cerebrospinal fluids in progressive supranuclear palsy

K. Hirayama, T. Yamada, M. Asahina, 1994, Acta neurologica Scandinavica.

Immunohistochemistry with an antibody to human liver carboxylesterase in human brain tissues

T. Yamada, H. Akatsu, T. Satoh, 1994, Brain Research.

Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease

W. Jefferies, Y. Tsuboi, J. Taguchi, 1999, Brain Research.

[Cobb syndrome and Klippel-Trenaunay-Weber syndrome].

K. Hirayama, M. Kawamura, T. Fukutake, 1991, Rinsho shinkeigaku = Clinical neurology.

Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease

K. Hirayama, I. Tooyama, P. Mcgeer, 1994, Acta Neuropathologica.

Risk factors for cerebral arteriosclerosis in Parkinson's disease.

M. Asahina, I. Moroo, T. Yamada, 1996, Parkinsonism & related disorders.